Cargando…
SUMO‐modified insulin‐like growth factor 1 receptor (IGF‐1R) increases cell cycle progression and cell proliferation
Increasing number of studies have shown nuclear localization of the insulin‐like growth factor 1 receptor (nIGF‐1R) in tumor cells and its links to adverse clinical outcome in various cancers. Any obvious cell physiological roles of nIGF‐1R have, however, still not been disclosed. Previously, we rep...
Autores principales: | Lin, Yingbo, Liu, Hongyu, Waraky, Ahmed, Haglund, Felix, Agarwal, Prasoon, Jernberg‐Wiklund, Helena, Warsito, Dudi, Larsson, Olle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518303/ https://www.ncbi.nlm.nih.gov/pubmed/28112398 http://dx.doi.org/10.1002/jcp.25818 |
Ejemplares similares
-
Nuclearly translocated insulin-like growth factor 1 receptor phosphorylates histone H3 at tyrosine 41 and induces SNAI2 expression via Brg1 chromatin remodeling protein
por: Warsito, Dudi, et al.
Publicado: (2016) -
Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers
por: Yang, Chen, et al.
Publicado: (2020) -
Targeting the IGF-1R signaling and mechanisms for epigenetic gene silencing in human multiple myeloma
por: Jernberg-Wiklund, Helena, et al.
Publicado: (2012) -
Growth signals employ CGGBP1 to suppress transcription of Alu-SINEs
por: Agarwal, Prasoon, et al.
Publicado: (2014) -
CGGBP1 mitigates cytosine methylation at repetitive DNA sequences
por: Agarwal, Prasoon, et al.
Publicado: (2015)